Agios Pharmaceuticals, Inc.
AS63404 is Agios Pharmaceuticals, Inc. (agios.com). It announces 768 IPv4 addresses in 3 prefixes, and 0 IPv6 prefixes.
United States· ARIN· allocated 2015-02-25· Business
Where its space is
The IPv4 it announces that IP Geolocation places, by country. A /24 counts for the AS announcing most of it.
- United States768 · 100.00%
Registry record
Its ASN Whois record, as the registry publishes it.
- handle
- AGIOS
- name
- Agios Pharmaceuticals, Inc.
- org
- AP-520
- org name
- Agios Pharmaceuticals, Inc.
- org address
- 38 Sidney Street, 2nd flr., Cambridge, MA, 02139
- org city
- Cambridge
- org country
- US
- country
- US
- source
- arin
- created
- 2015-02-25
- updated
- 2015-02-25
- abuse name
- IT Administrator
- abuse email
- domains@agios.com
- abuse phone
- +1-617-649-8600
- abuse kind
- role
- abuse city
- Cambridge
- abuse country
- US
- admin name
- IT Administrator
- admin email
- domains@agios.com
- admin phone
- +1-617-649-8600
- admin kind
- role
- admin city
- Cambridge
- admin country
- US
- tech name
- IT Administrator
- tech email
- domains@agios.com
- tech phone
- +1-617-649-8600
- tech kind
- role
- tech city
- Cambridge
- tech country
- US
- abuse validated
- 1
What the databases see
Addresses each address-keyed database holds in the IPv4 it announces, as a share of that space, with its largest providers. Counts overlap.
- 0.26%
- None here
- None here
- None here
- None here
- None here
- None here
- Hosting IP25633.33%
- None here
- None here
- None here
- None here
- None here
- None here
- None here
- Web IP192.47%
- None here
IPv4 prefixes
Every IPv4 prefix BGP Route saw it announce. A prefix another AS also announces says so.
| PREFIX | COUNTRY | RPKI | PEERS | FIRST SEEN |
|---|---|---|---|---|
| 38.111.34.0/24 | United States | Not found | 17 | 2026-10-02 |
| 38.111.49.0/24 | United States | Not found | 17 | 2026-10-02 |
| 38.111.52.0/24 | United States | Not found | 17 | 2026-10-02 |
Test the real build first.
An evaluation license puts a full current build in your hands, with no sampling, so you can measure it against your own traffic before anyone talks about terms.